Ligand Pharmaceuticals Inc
LGND
ISIN null / Valor 12015449
Ligand Pharmaceuticals Inc
UMushroom community rating:
About company
Ligand Pharmaceuticals Inc. is a publicly traded biopharmaceutical company based in San Diego that builds value by acquiring and developing drug technologies and by structuring partnerships that generate royalties, milestone payments and license fees rather than commercializing most drugs itself. The company owns or licenses discovery and enabling platforms—most notably the OmniAb antibody-discovery platform and the Captisol solubilization technology—and invests in or acquires programs and assets it then out-licenses to partner companies, retaining financial upside through royalty and milestone arrangements. Ligand’s business model emphasizes assembling a diversified portfolio of partnered programs across multiple therapeutic areas and extracting revenue from downstream product sales and development milestones.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
6017 M
Market cap (USD)
183,047
Daily traded volume (Shares)
108.05 / 105.33
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
